Latest
TipRanks Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 1283
- Sources here
- 13
- Companies here
- 22
Search results
Stored financial headlines
Active search
1283 matching headlines
Ticker or company: UGMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Plug Power Shares Advance 6.4%, Still Face 34% Sales Hurdle to Meet Targets
Plug Power (NASDAQ: PLUG) shares rose 6.4% after stronger-than-expected Q2 earnings, exceeding revenue consensus by 11.4% and narrowing adjusted loss. Despite increasing its 2026 revenue growth forecast to 15%-16%, the company faces a significant challenge, requiring a 34% increase in revenue for each of …
PLUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +38.1% · Next-week setup negative 42.7%
Russell Investments Group Ltd. Increases Stake in Plug Power, Inc. $PLUG
Russell Investments Group Ltd. significantly increased its stake in Plug Power, Inc. by 553.9% in the second quarter, acquiring over 600,000 additional shares. This comes as Plug Power reported improved Q2 revenue and margins, beating estimates, and raised its full-year outlook. Despite positive sentiment …
PLUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +38.1% · Next-week setup negative 42.7%
Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key Readouts
Ocugen is aiming for 2027 Biologics License Application (BLA) filings for its OCU400 retinitis pigmentosa and OCU410ST Stargardt disease gene therapies, with potential launches in 2028. The company expects key clinical readouts next year, including Phase III OCU400 data in Q1 and Phase II/III …
OCGN
main company
Sharemaestro market context
Price below Trend Line
52 weeks +33.7%
(HHH) Risk Channels and Responsive Allocation
The Howard Hughes Corporation (NYSE: HHH) is exhibiting weak sentiment, with a mid-channel oscillation pattern identified. AI models suggest an exceptional 41.2:1 risk-reward setup, targeting a 12.1% gain against 0.3% risk. Three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—have been generated, each …
HHH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -11.8%
Q2 2026 Ocugen Inc Earnings Call Transcript
Ocugen Inc. (OCGN) reported its Q2 2026 earnings, detailing both positive developments like FDA clearance for its Phase 3 trial for OCU410 and extended cash runway into 2028, and negative aspects such as a wider net loss and increased operating expenses. The company is …
OCGN
main company
Sharemaestro market context
Price below Trend Line
52 weeks +33.7%
(DEI) and the Role of Price-Sensitive Allocations
Douglas Emmett Inc. (NYSE: DEI) is showing a near-term neutral sentiment, suggesting a pause in mid and long-term weakness. The article highlights an exceptional 48.7:1 risk-reward short setup with potential downside of 15.9% versus 0.3% risk. AI models have generated three distinct trading strategies …
DEI
main company
Sharemaestro market context
Trend signal active
52 weeks -21.0%
Why Plug Power (PLUG) Is Up 6.4% After Raising 2026 Guidance and Targeting Positive EBITDA
Plug Power (PLUG) shares rose 6.4% after the company reported Q2 2026 results, raising its full-year 2026 revenue growth guidance to 15-16% and targeting positive adjusted EBITDA by Q4 2026. This improved outlook is driven by a strong commercial backlog, operational progress, and better …
PLUG
main company
Sharemaestro market context
Price below Trend Line
52 weeks +38.1% · Next-week setup negative 42.7%
Douglas Elliman (NYSE:DOUG) Rating Increased to Buy at Wall Street Zen
Wall Street Zen has upgraded Douglas Elliman (NYSE:DOUG) from a "sell" to a "buy" rating, despite other analysts like Weiss Ratings maintaining a "sell" rating. The real estate brokerage firm, with a market capitalization of $184.1 million, recently reported a quarterly loss of $0.05 …
DOUG
main company
Sharemaestro market context
Price above Trend Line
52 weeks -23.7% · Next-week setup negative 41.8%
UGI (NYSE:UGI) Cut to "Sell" at Wall Street Zen
Wall Street Zen downgraded UGI (NYSE:UGI) from "Hold" to "Sell," citing a missed earnings expectation of ($0.20) per share against an estimated ($0.08) loss and revenue of $1.33 billion falling short of the $1.50 billion consensus. This follows similar rating adjustments from other firms, …
UGI
main company
Sharemaestro market context
Price below Trend Line
52 weeks +4.4% · Next-week setup positive 55.9%
Douglas Emmett (NYSE:DEI) Raised to Hold at Wall Street Zen
Wall Street Zen has upgraded Douglas Emmett (NYSE:DEI) from a "sell" to a "hold" rating, aligning with the broader analyst consensus of "Hold" and a target price of $13.71. Despite missing EPS estimates in its latest quarter, the company's revenue exceeded expectations, and its …
DEI
main company
Sharemaestro market context
Trend signal active
52 weeks -21.0%
Ocugen, Inc. (NASDAQ:OCGN) Receives Average Rating of "Moderate Buy" from Analysts
Ocugen, Inc. (NASDAQ:OCGN) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $9.50. Insider buying by CFO Treerita Essali Johnson-Greene and increased institutional holdings indicate positive sentiment, though the stock has been under pressure after reporting a …
OCGN
main company
Sharemaestro market context
Price below Trend Line
52 weeks +33.7%
How Howard Hughes’ Return To Profitability And Strong Q2 2026 Earnings At Howard Hughes Holdings (HHH) Has Changed Its Investment Story
Howard Hughes Holdings (HHH) reported a significant return to profitability in Q2 2026, with sales of US$222.43 million and a net income of US$158.37 million, reversing a net loss from the previous year. This turnaround, driven partly by strong revenue from The Park Ward …
HHH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -11.8%